Assessing demographic, clinical and pathological determinants of advances prostate cancer in Indonesia for delayed diagnosis, treatment, and risk for secondary progression and survival
Not Applicable
- Conditions
- Biomarker predicting the outcome of Androgen Deprivation Therapies and Chemotherapies in Prostate Cancer patientsCancer
- Registration Number
- ISRCTN24834343
- Lead Sponsor
- Fakultas Kedokteran, Kesehatan Masyarakat dan Keperawatan UGM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Male
- Target Recruitment
- 300
Inclusion Criteria
1. Diagnosed with advanced prostate cancer
2. Aged 18 - 80 years
Exclusion Criteria
1. Received systemic chemotherapy, targeted therapy, and immunomodulatory therapy prior study
2. Received local therapy including radical prostatectomy, radiotherapy, and other local therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method